Xconomy: Agenda

Wednesday, May 16

12:30 – 1:30	Registration and Networking
1:30 – 1:35	Welcome and Opening Remarks Bob Buderi, Xconomy
1:35 – 1:55	Opening Keynote Eric Lander, Broad Institute of MIT and Harvard
1:55 – 2:25	Setting the Price, And Value, of U.S. Gene Therapies Dan Ollendorf, Institute for Clinical and Economic Review John Furey, Spark Therapeutics Michael Sherman, Harvard Pilgrim Health Care Michael Pace, ICON (moderator)
2:30 – 3:00	Future Founders: Opening Doors for Young Biotech Entrepreneurs Anna Greka, Goldfinch Biopharma; Broad Institute of MIT and Harvard Amy Schulman, Lyndra; Polaris Partners Cigall Kodach, Foghorn Therapeutics; Broad Institute of MIT and Harvard Teresa Lavoie, Fish and Richardson (moderator)
3:00 – 3:30	CAR-T: The Early Launch and What’s to Come Caron Jacobson, Dana-Farber Cancer Institute Andreas Klein, Tufts Medical Center Corie Lok, Xconomy (moderator)
3:30 – 4:00	Networking Break
4:00 – 4:30	Gene Editing’s Next Frontier: Human Trials Feng Zhang, Broad Institute of MIT and Harvard Kara Miller, WGBH (moderator)
4:30 – 4:50	mRNA: From Vaccines to Therapeutics Stephen Hoge, Moderna
4:50 – 5:20	RNAi: From Lab Experiment to FDA Review Craig Mello, University of Massachusetts Medical School, RNA Therapeutics Institute Barry Greene, Alnylam Pharmaceuticals Samantha Singer, Broad Institute of MIT and Harvard (moderator)
5:20 – 6:30	Networking Reception

Please note that this schedule is subject to change.